Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Somatuline Autogel 120 mg, solution for injection in a prefilled syringe

Active Ingredient:
lanreotide acetate
Company:  
ATC code: 
H01CB03
{info_black}
About Medicine
This product is now known as ‘Lanreotide Ipsen

Somatuline Autogel 60mg, 90mg and 120mg solution for injection in a pre-filled syringe PL 34926/0005-7.

Please note that a new syringe system for the above products has been released into the market from the end of June 2019. The current and new syringes will both be available on the market for a period of time.

The new syringe system is presented within a plastic tray in the pouch supplied in the carton. The previous version was supplied in the pouch without a plastic tray.

The instructions for use in the patient leaflet have been updated to reflect the new syringe system. The SmPC and the patient leaflet on eMC reflect the new syringe system.

Please refer to the patient leaflet provided in the pack before administering the product, as this may have changed since your last injection.

For further information please contact Medical Information on 01753 627777 or [email protected]
Ipsen Ltd
Company image
Address
190 Bath Road, Slough, Berkshire, SL1 3XE
Telephone
+44 (0)1753 627 777
Medical Information Direct Line
+44 (0)1753 627 777
Medical Information e-mail
[email protected]
Customer Care direct line
+44 (0)1753 627 627